Keeping pace with the growth of the Korean biopharmaceutical market, we will continue to grow as a company that contributes to the development of high-quality, high-value-added medicines by providing solutions with high satisfaction based on state-of-the-art technology.
Ajinomoto CELLiST Korea’s CELLiST™ BASAL Media for Chinese Hamster Ovary (CHO) cell lines are developed based on Ajinomoto’s strong capabilities in amino acid technology and over 30 years of experience in the cell culture media business.